Eton Pharmaceuticals, Inc. (ETON)
Largest Insider Buys in Sector
ETON Stock Price History Chart
ETON Stock Performance
About Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically …
Insider Activity of Eton Pharmaceuticals, Inc.
Over the last 12 months, insiders at Eton Pharmaceuticals, Inc. have bought $1.02M and sold $0 worth of Eton Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Eton Pharmaceuticals, Inc. have bought $983,754 and sold $20.77M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Opaleye Management Inc. (10 percent owner) — $6.11M.
The last purchase of 10,000 shares for transaction amount of $79,814 was made by Opaleye Management Inc. (10 percent owner) on 2024‑10‑23.
List of Insider Buy and Sell Transactions, Eton Pharmaceuticals, Inc.
| 2024-10-23 | 10 percent owner | 10,000 0.0782% | $7.98 | $79,814 | +30.38% | |||
| 2024-10-08 | 10 percent owner | 33,970 0.2339% | $7.03 | $238,782 | +33.31% | |||
| 2024-10-07 | 10 percent owner | 11,248 0.0796% | $7.22 | $81,250 | +33.01% | |||
| 2024-10-04 | 10 percent owner | 16,852 0.1118% | $6.77 | $114,105 | +34.86% | |||
| 2024-09-11 | 10 percent owner | 50,000 0.2326% | $4.75 | $237,500 | +76.20% | |||
| 2024-09-10 | 10 percent owner | 57,500 0.2619% | $4.65 | $267,375 | +76.36% | |||
| 2022-09-22 | Chief Executive Officer | 10,000 0.0382% | $2.10 | $21,042 | +61.29% | |||
| 2021-11-17 | Sale | 10 percent owner | 25,000 0.1% | $4.67 | $116,713 | -31.32% | ||
| 2021-11-16 | Sale | 10 percent owner | 12,438 0.0495% | $4.86 | $60,472 | -34.12% | ||
| 2021-11-15 | Sale | 10 percent owner | 3,000 0.0112% | $4.80 | $14,405 | -37.28% | ||
| 2021-11-08 | Sale | 10 percent owner | 52,661 0.2268% | $6.10 | $321,285 | -41.81% | ||
| 2021-11-05 | Sale | 10 percent owner | 167,701 0.6665% | $6.30 | $1.06M | -46.74% | ||
| 2021-11-04 | Sale | 10 percent owner | 85,700 0.3409% | $6.44 | $551,651 | -47.20% | ||
| 2021-11-03 | Sale | 10 percent owner | 116,500 0.4622% | $6.53 | $760,850 | -47.32% | ||
| 2021-10-12 | Sale | 10 percent owner | 87,307 0.3414% | $5.06 | $441,485 | -28.85% | ||
| 2021-10-11 | Sale | 10 percent owner | 34,101 0.136% | $5.01 | $170,716 | -26.61% | ||
| 2021-10-08 | Sale | 10 percent owner | 43,692 0.1737% | $5.00 | $218,469 | -26.45% | ||
| 2021-08-20 | President & CEO | 10,000 0.0388% | $4.32 | $43,200 | -12.02% | |||
| 2021-08-20 | CFO, Treasurer & Secretary | 5,000 0.0199% | $4.43 | $22,150 | -12.02% | |||
| 2021-08-06 | Sale | 10 percent owner | 345,000 1.358% | $5.84 | $2.01M | -32.88% |
Insider Historical Profitability
| Opaleye Management Inc. | 10 percent owner | 2770000 10.3999% | $12.53 | 7 | 17 | <0.0001% |
| BRYNJELSEN SEAN | Chief Executive Officer | 1040000 3.9047% | $12.53 | 7 | 0 | <0.0001% |
| CASAMENTO CHARLES J | director | 71920 0.27% | $12.53 | 2 | 0 | +1.97% |
| RIEDEL NORBERT G | director | 59745 0.2243% | $12.53 | 1 | 0 | +7.11% |
| MAIER PAUL V | director | 59745 0.2243% | $12.53 | 1 | 0 | +7.11% |